Skip to content
Screener

BioMarin Pharmaceuticals BMRN Price / book

Price / book at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
1.2×-0.1×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
3.9×-0.4×
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
2.2×+0.7×
Regenxbio logo
RegenxbioRGNX
8.6×+6.6×
Tyra Biosciences, Inc. logo
Tyra Biosciences, Inc.TYRA
5.3×+3.8×
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
3×+0.5×

Other financials

Income statement

See full
Revenue$989.7M+19.9%
Gross profit$786.9M+16.5%
Operating income$110.9M-59.9%
Net income$44.8M-81.4%
EPS (diluted)$0.23-81.3%

Balance sheet

See full
Cash & equivalents$874.0M-28.0%
Total debt$4.2B+598%
Total equity$6.3B+4.9%
Total assets$11.7B+57.2%

Cash flow

See full
Operating cash flow$168.1M-9.3%
CapEx$28.8M+68.5%
Free cash flow$139.3M-17.2%

Valuation

See full
Market cap$11.58B-0.6%
Enterprise value$14.89B+34.9%
P/E32.2×-34.7×
P/S3.4×-0.4×

Profitability

See full
Gross margin76.1%-3.4pp
Operating margin19.9%+7.2pp
Net margin16.8%+5.1pp
FCF margin21.7%-1.0pp

Returns & leverage

See full
Return on equity9.1%+2.8pp
Debt / equity0.7×+0.6×
Current ratio2.4×-3.2×

Where this comes from

Calculated from BioMarin Pharmaceuticals’s reported figures.

market cap/total stockholders equity=1.7×

Based on the most recent quarter.

The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001048477-26-000016

FAQ

What is BioMarin Pharmaceuticals's price / book?
BioMarin Pharmaceuticals (BMRN) reported price / book of 1.7× in Q2 2026.
How has BioMarin Pharmaceuticals's price / book changed year-over-year?
BioMarin Pharmaceuticals's price / book increased by 0.5% year-over-year, from 1.7× to 1.7×.
What is the long-term trend for BioMarin Pharmaceuticals's price / book?
Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's price / book has grown at a -13.7% compound annual growth rate (CAGR), from 3.9× to 1.9×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about BioMarin Pharmaceuticals's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude